• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 UHPLC-QTOF-MS 测定人尿液和血浆中的沙美特罗、α-羟沙美特罗和丙酸氟替卡松用于兴奋剂检测。

Determination of salmeterol, α-hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS.

机构信息

Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Centre for Scientific Resarch "Demokritos", Maroussi, Greece.

Faculty of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Biomed Chromatogr. 2021 Aug;35(8):e5114. doi: 10.1002/bmc.5114. Epub 2021 Apr 11.

DOI:10.1002/bmc.5114
PMID:33720401
Abstract

Salmeterol and fluticasone are included in the Prohibited List annually issued by the World Anti-Doping Agency. While for other permitted beta-2 agonists a threshold has been established, above which any finding constitutes an Adverse Analytical Finding, this is not the case with salmeterol. The salmeterol metabolite, α-hydroxysalmeterol, has been described as a potentially more suitable biomarker for the misuse of inhaled salmeterol. In this study, a new and rapid UHPLC-QTOF-MS method was developed and validated for the simultaneous quantification of salmeterol, α-hydroxysalmeterol and fluticasone in human urine and plasma, which can be used for doping control. The analytes of interest were extracted by means of solid phase extraction and were separated on a Zorbax Eclipse Plus C column. Detection was performed in a quadrupole time-of-flight mass spectrometer equipped with an electrospray ionization source, in positive mode for the detection of salmeterol and its metabolite and in negative mode for the detection of fluticasone. Method was validated over a linear range from 0.10 to 2.00 ng/ml for salmeterol and fluticasone, and from 1.00 to 20.0 ng/ml for α-hydroxysalmeterol, in urine, whereas in plasma, the linear range was from 0.025 to 0.500 ng/ml for salmeterol and fluticasone, respectively.

摘要

沙美特罗和氟替卡松每年都被世界反兴奋剂机构列入禁用清单。虽然对于其他允许使用的β2-激动剂,已经确定了一个阈值,超过这个阈值的任何发现都构成了不利的分析结果,但沙美特罗并非如此。沙美特罗的代谢物α-羟沙美特罗已被描述为一种更适合用于检测吸入用沙美特罗滥用的潜在生物标志物。在这项研究中,开发并验证了一种新的快速 UHPLC-QTOF-MS 方法,用于同时定量检测人尿液和血浆中的沙美特罗、α-羟沙美特罗和氟替卡松,可用于兴奋剂控制。通过固相萃取提取感兴趣的分析物,并在 Zorbax Eclipse Plus C 柱上进行分离。在配备电喷雾电离源的四极杆飞行时间质谱仪中以正模式检测沙美特罗及其代谢物,以负模式检测氟替卡松进行检测。该方法在尿液中沙美特罗和氟替卡松的线性范围为 0.10-2.00 ng/ml,α-羟沙美特罗的线性范围为 1.00-20.0 ng/ml;而在血浆中,沙美特罗和氟替卡松的线性范围分别为 0.025-0.500 ng/ml。

相似文献

1
Determination of salmeterol, α-hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS.采用 UHPLC-QTOF-MS 测定人尿液和血浆中的沙美特罗、α-羟沙美特罗和丙酸氟替卡松用于兴奋剂检测。
Biomed Chromatogr. 2021 Aug;35(8):e5114. doi: 10.1002/bmc.5114. Epub 2021 Apr 11.
2
Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.沙美特罗及其主要代谢物 α-羟沙美特罗在进行性耐力训练的男性急性和慢性干粉吸入后的药代动力学:对兴奋剂控制的影响。
Drug Test Anal. 2021 Apr;13(4):747-761. doi: 10.1002/dta.2978. Epub 2020 Nov 23.
3
Development of a sensitive method for simultaneous determination of fluticasone propionate and salmeterol in plasma samples by liquid chromatography-tandem mass spectrometry.
Biomed Chromatogr. 2012 May;26(5):627-35. doi: 10.1002/bmc.1708.
4
Rapid chiral high-performance liquid chromatographic assay for salmeterol and alpha-hydroxysalmeterol. Application to in vitro metabolism studies.沙美特罗和α-羟基沙美特罗的快速手性高效液相色谱测定法。应用于体外代谢研究。
J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):225-30. doi: 10.1016/s0378-4347(99)00156-5.
5
The salmeterol anomaly and the need for a urine threshold.沙美特罗异常与尿阈需求。
Drug Test Anal. 2022 Jun;14(6):997-1003. doi: 10.1002/dta.2810. Epub 2020 Jun 8.
6
Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.吸入给药后尿中(R)-沙美特罗和(S)-沙美特罗的对映体选择性分布及其在兴奋剂检测中的应用
Drug Test Anal. 2017 Aug;9(8):1262-1266. doi: 10.1002/dta.2131. Epub 2016 Dec 29.
7
Simultaneous quantitative determinations of fluticasone propionate and salmeterol xinafote in diskus inhalers.准纳器吸入器中丙酸氟替卡松和昔萘酸沙美特罗的同步定量测定
Drug Metab Lett. 2014;8(1):31-5. doi: 10.2174/187231280801140929161136.
8
Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations.沙美特罗与丙酸氟替卡松之间的相互作用及其对人血浆中低皮克/毫升浓度下液相色谱/串联质谱测定法定量准确性的影响研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Dec 15;876(2):163-9. doi: 10.1016/j.jchromb.2008.10.034. Epub 2008 Oct 25.
9
The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.
Drug Metab Dispos. 1996 May;24(5):555-9.
10
Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration levels.在低皮克/毫升浓度水平下,通过液相色谱/串联质谱法测定人血浆中沙美特罗的方法开发中,将基质效应降至最低。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):285-93. doi: 10.1016/j.jchromb.2007.06.010. Epub 2007 Jun 22.